Inventor · disambiguated record
Jon A. Kenniston
Also filed as: KENNISTON JON · KENNISTON JON A
11 granted patents·6 pending applications·57 citations·filing 2014–2025
88Inventor score
Top patents by PatentIndex Score
17 records- 0195US12110343B2Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 8, 2024·4 cites·10 claims
- 0295US11084884B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 10, 2021·23 cites·17 claims
- 0392US11299553B2Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 12, 2022·8 cites·16 claims
- 0490US11372002B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jun 28, 2022·9 cites·15 claims
- 0587US11156612B2Methods of determining levels of cleaved and/or intact kininogenTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 26, 2021·6 cites·15 claims
- 0684US2025129182A1Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0783US12384854B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Aug 12, 2025·1 cites·15 claims
- 0880US10913802B2Monoclonal antibody inhibitor of factor XIIADYAX CORP·Filed 2016·Granted Feb 9, 2021·3 cites·15 claims
- 0979US11390687B2Bispecific antibodies against plasma kallikrein and Factor XIITAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 19, 2022·3 cites·26 claims
- 1075US12442824B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Oct 14, 2025·0 cites·9 claims
- 1166US12240918B2Bispecific antibodies against plasma kallikrein and factor XIITAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Mar 4, 2025·0 cites·16 claims
- 1264US12415866B2Monoclonal antibody inhibitor of Factor XIIaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 16, 2025·0 cites·13 claims
- 1364US2022170936A1Evaluation and treatment of bradykinin-mediated disordersTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1459US2016017055A1Anti-plasma kallikrein antibodiesDYAX CORP·Filed 2014·Application pending·0 cites
- 1551US2022186252A1Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikreinTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1644US2025263504A1Bispecific antibodies against plasma kallikrein and factor xiiTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1743US2023038502A1Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikreinSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jon A. Kenniston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →